In a statement before the lawsuit, the US Food and Drug Administration told CNN it had received reports of gastroparesis with semaglutide and liraglutide, some of which documented the adverse event as not recovered after discontinuation of the respective product at the time of the report. Ozempics prescribing information says the most common adverse events related to the drug are nausea, vomiting, diarrhea, abdominal pain and constipation
After the lawsuit, the FDA paused enforcement but reasserted its position in December
There are several phase 3 trials evaluating GLP-1s for indications, such as metabolic dysfunction-associated steatohepatitis (MASH), prediabetes, Alzheimer's disease, diabetic retinopathy, and osteoarthritis of the knee (in patients with obesity)
The key is in finding a diet that includes enough protein and overall nutrients
during, or after surgery)